HTA31 Cost-Utility Analysis of Pneumococcal Vaccines for Older Adults Available in Costa Rica

In Costa Rica, 13-valent pneumococcal conjugate vaccine (PCV13) and 23-valent pneumococcal polysaccharide vaccine (PPSV23) are available to prevent invasive pneumococcal disease (IPD) such as meningitis, bacteremia, as well as community-acquired pneumococcal pneumonia (CAP) caused by serotypes contained in these vaccines. This analysis estimated the clinical and economic values of PCV13 and PPSV23 from the public healthcare perspective.
Source: Value in Health - Category: International Medicine & Public Health Authors: Source Type: research